Of land, ancestral property and prophecy in Corinna PMG 654 col. iii ll. 37–39

Of land, ancestral property and prophecy in Corinna PMG 654 col. iii ll. 37–39

Bibliographic Details
Main Author:	Prauscello, L
Format:	Conference item
Published:	2018

Similar Items

Corinna - Eine Erscheinung
by: Bente Lucht
Published: (2022-06-01)

Heparan Sulfate Proteoglycan–Involving Immunomodulation by Cathelicidin Antimicrobial Peptides LL-37 and PR-39
by: Nicole C. Kaneider, et al.
Published: (2007-01-01)

The Genus Corinna (Araneae, Clubionidae) in Panama
by: Arthur M. Chickering
Published: (1972-01-01)

Architecture and Mathematics in Ancient Egypt by Corinna Rossi
by: Sarah Symons
Published: (2005-08-01)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
by: Roberto Lande, et al.
Published: (2020-05-01)

Themistocles’ philotimia in IEleusis 300 (= SEG 30.93) ll. 65-67: some linguistic observations
by: Prauscello, L
Published: (2019)

Regulation of LL-37 in Bone and Periodontium Regeneration
by: Zahra Chinipardaz, et al.
Published: (2022-09-01)

Time Category in Novel “Corinna, or Italy” by Germaine de Staël
by: T. V. Nuzhnaya
Published: (2018-02-01)

Nature Images in Novel by G. de Stael “Corinna, or Italy”
by: T. V. Nuzhnaya
Published: (2017-02-01)

‘Divine Corinna’: Pre-Twentieth Century Receptions of an Artistic Authority
by: Thea S. Thorsen
Published: (2020-01-01)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
by: Joanna Tokajuk, et al.
Published: (2022-05-01)

An Unexplored Molecule in the Diagnosis of Allergic Rhinitis: LL-37
by: Erkan Yıldız, et al.
Published: (2023-07-01)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
by: Juanfeng Lao, et al.
Published: (2023-03-01)

Redemption: wine and prophecy in the land of Israel
by: McGonigle, Ian
Published: (2023)

Salivary Cathelicidin (LL-37) in Children and Adolescents Living with HIV
by: Ana Lucia Seminario, et al.
Published: (2024-01-01)

Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome
by: Fernando Chernomordik, et al.
Published: (2023-03-01)

Onoma 37–39. (2002–2004)
by: Judit Raátz, et al.
Published: (2008-12-01)

Corinna R. Unger: Entwicklungspfade in Indien. Eine internationale Geschichte, 1947–1980
by: Julia Sophie Schmidt
Published: (2019-11-01)

Interactions of the human cathelicidin peptide LL-37 with DNA by biophysical methods.
by: Tan, Zhenwei.
Published: (2009)

Serum Levels of LL-37 and Inflammatory Cytokines in Plaque and Guttate Psoriasis
by: Young Ji Hwang, et al.
Published: (2014-01-01)

Vitamin D and LL-37 in Serum and Saliva: Insights into Oral Immunity
by: Sotiria Davidopoulou, et al.
Published: (2025-02-01)

LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases
by: Surajit Bhattacharjya, et al.
Published: (2024-03-01)

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
by: Kylen E. Ridyard, et al.
Published: (2021-05-01)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
by: Oriana Simonetti, et al.
Published: (2021-10-01)

LL-37, a Multi-Faceted Amphipathic Peptide Involved in NETosis
by: Marko Radic, et al.
Published: (2022-08-01)

Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
by: Lilla Szabó, et al.
Published: (2023-06-01)

Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis.
by: Masamoto Murakami, et al.
Published: (2014-01-01)

LL-37 induces polymerization and bundling of actin and affects actin structure.
by: Asaf Sol, et al.
Published: (2012-01-01)

prophecy /
by: Haydon, Elizabeth
Published: (2000)

Antimicrobial Properties and Cytotoxicity of LL-37-Derived Synthetic Peptides to Treat Orthopedic Infections
by: Vincenzo Pennone, et al.
Published: (2024-08-01)

Anisodamine (654-1/654-2) ameliorates septic kidney injury in rats by inhibiting inflammation and apoptosis
by: Dong Liu, et al.
Published: (2024-09-01)

Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease
by: Shuo Miao, et al.
Published: (2024-12-01)

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
by: Bapi Pahar, et al.
Published: (2020-09-01)

Characterization of circulating extracellular traps and immune responses to citrullinated LL37 in psoriasis
by: María Teresa Martín Monreal, et al.
Published: (2023-12-01)

Effects of LL-37 on Gingival Fibroblasts: A Role in Periodontal Tissue Remodeling?
by: Maelíosa T. C. McCrudden, et al.
Published: (2018-07-01)

Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
by: Fatai Lu, et al.
Published: (2022-08-01)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
by: Ibrahim H. Babikir, et al.
Published: (2018-01-01)

The effects of Economic Policy Uncertainty on the Insurance Industry (PMG approach)
by: amir ali farhang
Published: (2022-05-01)

Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37
by: Haiwei Zhuo, et al.
Published: (2022-06-01)

Origen and prophecy
by: Hall, C
Published: (2018)